Immediate Impact
56 standout
Citing Papers
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
2024 Standout
Understanding the complexity of p53 in a new era of tumor suppression
2024 Standout
Works of Saori Ishida being referenced
A HER2-Targeting Antibody–Drug Conjugate, Trastuzumab Deruxtecan (DS-8201a), Enhances Antitumor Immunity in a Mouse Model
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Saori Ishida | 135 | 20 | 20 | 198 | 122 | 13 | 402 | |
| J.H. Johnson | 130 | 36 | 3 | 99 | 36 | 11 | 438 | |
| Mark Sturmoski | 169 | 67 | 23 | 151 | 65 | 9 | 441 | |
| Semra Aygun‐Sunar | 158 | 32 | 27 | 49 | 68 | 12 | 436 | |
| Norbert Madry | 237 | 12 | 4 | 89 | 35 | 17 | 401 | |
| Raphaël Boisgard | 90 | 29 | 12 | 39 | 114 | 12 | 346 | |
| C. A. Chadwick | 139 | 42 | 2 | 71 | 36 | 10 | 353 | |
| Charnell I. Sommers | 108 | 18 | 8 | 70 | 90 | 15 | 356 | |
| Ginette Balboni | 133 | 232 | 4 | 176 | 15 | 17 | 448 | |
| Katrina Adlerz | 149 | 14 | 8 | 33 | 25 | 11 | 375 | |
| Bojana Bojović | 227 | 74 | 23 | 156 | 11 | 18 | 372 |
All Works
Loading papers...